AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Photocure ASA

Report Publication Announcement Sep 3, 2019

3714_rns_2019-09-03_b59742eb-a6a7-4eb0-9f8f-9e18fc9caac5.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Photocure to present at the H.C. Wainwright 21st Annual Healthcare Conference in New York

Photocure to present at the H.C. Wainwright 21st Annual Healthcare Conference in New York

Oslo, Norway, 3 September 2019, - Photocure ASA (OSE: PHO) management will be

presenting at the 21st Annual Healthcare Conference to investors and industry

peers in New York (US) on September 9 at 10:50 EDT. The conference is sponsored

by H.C. Wainwright & Co. The presentation will be posted on www.photocure.com

when held on September 9, 2019.

Company contact:

Erik Dahl

Chief Financial Officer

Tel: +47 450 55 000

Email: [email protected]

About Photocure ASA

Photocure, The Bladder Cancer Company, delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, which makes

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com or www.cysview.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.